Evidence map›Paper›PMID 39404417›Full record

ArticleCells2024

Neddylation and Its Target Cullin 3 Are Essential for Adipocyte Differentiation.

Hongyi Zhou, Vijay Patel, Robert Rice, Richard Lee, Ha Won Kim, Neal L Weintraub, Huabo Su, Weiqin Chen

Abstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Adipose cullin 3 mediates the antiobesity effect of pan neddylation inhibitors.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hongyi ZhouDepartments of Physiology, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.ORCID 0000-0001-5074-5180
Vijay PatelDepartment of Surgery, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
Robert RiceDepartment of Surgery, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
Richard LeeDepartment of Surgery, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
Ha Won KimDepartment of Medicine, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.ORCID 0000-0001-6272-4248
Neal L WeintraubDepartment of Medicine, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.ORCID 0000-0002-5138-3705
Huabo SuVascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.ORCID 0000-0002-8475-2685
Weiqin ChenDepartments of Physiology, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.

Funding

Neddylation and cardiac protein quality controlR01HL124248 · NHLBI · AUGUSTA UNIVERSITY · PI SU, HUABO · 2014 to 2024
$4.1M
Novel Role of Bscl2 in Cardiac Substrate Metabolism and FunctionR01HL132182 · NHLBI · AUGUSTA UNIVERSITY · PI Weiqin Chen · 2016 to 2026
$4.1M
Mitochondrial quality control in the heartR01HL165205 · NHLBI · AUGUSTA UNIVERSITY · PI SU, HUABO · 2022 to 2025
$2.4M
Elucidating the role of Cullin 3 in the heartR01HL173796 · NHLBI · AUGUSTA UNIVERSITY · PI Huabo Su · 2024 to 2026
$2.0M
Novel Posttranslational Modifications in Adipose BiologyR01DK135657 · NIDDK · AUGUSTA UNIVERSITY · PI Weiqin Chen · 2024 to 2026
$1.3M
Mitochondrial stress in liver function and dysfunctionR56DK136753 · NIDDK · AUGUSTA UNIVERSITY · PI CHEN, WEIQIN · 2023 to 2023
$439k
Novel Posttranslational Modifications in Adipose BiologyR56DK135657 · NIDDK · AUGUSTA UNIVERSITY · PI CHEN, WEIQIN · 2023 to 2023
$154k
NHLBI NIH HHS R01 HL124248NHLBI NIH HHS R01 HL132182NHLBI NIH HHS R01 HL165205NHLBI NIH HHS R01 HL173796NIDDK NIH HHS R01 DK135657NIDDK NIH HHS R56 DK135657NIDDK NIH HHS R56 DK136753NIH HHS 1R01DK135657-24A1NIH HHS 1R56DK135657-23A1NIH HHS 2R01HL132182-24A1
6 · The paper itself

Abstract

The ongoing obesity epidemic has raised awareness of the complex physiology of adipose tissue. Abnormal adipocyte differentiation results in the development of systemic metabolic disorders such as insulin resistance and diabetes. The conjugation of NEDD8 (neural precursor cell expressed, developmentally downregulated 8) to target protein, termed neddylation, has been shown to mediate adipogenesis. However, much remains unknown about its role in adipogenesis. Here, we demonstrated that neddylation and its targets, the cullin (CUL) family members, are differentially regulated during mouse and human adipogenesis. Inhibition of neddylation by MLN4924 significantly reduced adipogenesis of 3T3-L1 and human stromal vascular cells. Deletion of NAE1, a subunit of the only NEDD8 E1 enzyme, suppressed neddylation and impaired adipogenesis. Neddylation deficiency did not affect mitotic cell expansion. Instead, it disrupted CREB/CEBPβ/PPARγ signaling, essential for adipogenesis. Interestingly, among the neddylation-targeted CUL family members, deletion of CUL3, but not CUL1, CUL2, or CUL4A, largely replicated the adipogenic defects observed with neddylation deficiency. A PPARγ agonist minimally rescued the adipogenic defects caused by the deletion of NAE1 and CUL3. In conclusion, our study demonstrates that neddylation and its targeted CUL3 are crucial for adipogenesis. These findings provide potential targets for therapeutic intervention in obesity and metabolic disorders.

Indexed as

3T3-L1 CellsAdipocytesAdipogenesisCell DifferentiationCullin ProteinsNEDD8 ProteinAnimalsCyclopentanesHumansMicePPAR gammaPyrimidinesSignal TransductionUbiquitin-Activating EnzymesCUL3 protein, humanCul3 protein, mouseCullin ProteinsCyclopentanesNAE protein, humanNEDD8 ProteinNEDD8 protein, humanNedd8 protein, mousepevonedistatPPAR gammaPyrimidinesUbiquitin-Activating Enzymesadipogenesismetabolismneddylationobesitypost-translational modification

Identifiers

PMID39404417
PMCPMC11475318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.